Table 1.
Studies investigating biofilm forming bovine mastitis pathogens in animal models or the effect of possible antibacterial agents and vaccines in animal models.
| References | Year | Sample type | Focus of study | Pathogen | Experimental animal |
|---|---|---|---|---|---|
| Cucarella et al. (88) | 2001 | Bovine subclinical mastitis and human isolates | Molecular basis of biofilm | S. aureus | Mice |
| Brouillette et al. (44) | 2005 | Clinical bovine mastitis isolates | Antibacterial treatment | S. aureus | Mice |
| Gogoi-Tiwari et al. (85) | 2015 | Bovine mastitis isolates | Vaccine | S. aureus | Mice |
| Collado et al. (83) | 2016 | Clinical bovine mastitis isolates | Vaccine | S. uberis | Mice |
| Gogoi-Tiwari et al. (87) | 2016 | Bovine mastitis isolates | Vaccine | S. aureus | Mice |
| Mordmuang et al. (70) | 2019 | Bovine mastitis isolates | Antibacterial treatment | S. aureus | Mice |
| Montironi et al. (89) | 2019 | Subclinical bovine mastitis isolates, milk samples | Investigation of phenotype, genotype and virulence | Enterococcus faecium | Mice |
| Côté-Gravel et al. (84) | 2019 | Bovine mastitis isolates | Vaccine | S. aureus | Mice |
| Marbach et al. (90) | 2019 | Subclinical bovine mastitis isolates, milk samples | Interactions between host and bacteria | S. aureus | Mice |
| Wang et al. (72) | 2020 | Isolates (Purchased strains) | Antibacterial treatment | S. xylosus | Mice |
| Prenafeta et al. (86) | 2010 | Ruminant mastitis isolates | Vaccine | S. aureus | Heifers, cows |
| Savijoki et al. (91) | 2014 | Bovine mastitis isolates | Genomics and proteomics | S. epidermidis | Cows |
| Seroussi et al. (92) | 2018 | Bovine mastitis isolates | Antibacterial treatment | E. coli, S. aureus | Cows |
| Cucarella et al. (40) | 2004 | Bovine subclinical mastitis isolates | Molecular basis of biofilm | S. aureus | Sheep |